Brookline Capital (BCAC) Shareholders Approve Apexigen Deal
by Marlena Haddad on 2022-07-28 at 7:19am

Brookline Capital (NASDAQ:BCAC) announced in an 8-K this morning that its shareholders approved its combination with Apexigen at a special meeting July 27.

The filing did not include redemption figures, but the transaction also did not have a minimum cash condition beyond listing requirements. Brookline brought a $15 million PIPE alongside its trust in the deal and Lincoln Park also agreed to purchase up to $50 million of the combined entity’s stock in the two years following the transaction’s close.

Brookline traded below its estimated pro rata trust value of $10.22 throughout its July 25 redemption deadline, but has since soared to a close Wednesday at $10.75. Following the deal’s close, Apexigen is expected to trade on the Nasdaq under the symbol “APGN”.

The parties initially announced the $278 million combination on March 18. San Carlos, California-based Apexigen is developing a range of immunological cancer treatments with four currently in Phase II trials.

It announced the results of its Phase II trials to treat pancreatic cancer with its sotigalimab drug candidate in June.


  • Brookline Capital Markets is acting as capital markets advisor to Brookline Capital Acquisition Corp.
  • Wedbush PacGrow is acting as exclusive strategic financial advisor to Apexigen.
  • DLA Piper LLP (US) is serving as legal advisor to Brookline Capital Acquisition Corp.
  • Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal advisor to Apexigen.
Recent Posts
by Nicholas Alan Clayton on 2023-09-21 at 11:33am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  JSE reviewing listing requirements with aim to simplify them The Johannesburg Stock Exchange will be reviewing all its listings requirements with the objective of further simplifying its requirements, as part of its ongoing efforts to create an...

by Nicholas Alan Clayton on 2023-09-21 at 7:36am

Nabors Energy Transition Corp. (NYSE:NETC) announced this morning that Vast has added an equity commitment of up to $10 million to its combination with concentrated solar power producer Vast. The new commitment comes at $10.20 per share from the Canberra Airport Group and half of it is to come up front at close. A further...

by Nicholas Alan Clayton on 2023-09-21 at 7:08am

M3-Brigade III (NYSE:MBSC) announced this morning that it has closed its combination with Canadian energy producer Greenfire and the combined company is expected to trade on the NYSE under the symbol “GFR” later today. Concurrent with close, Greenfire also issued $300 million in new senior secured notes at a 2% discount, priced at $980 per...

by Kristi Marvin on 2023-09-20 at 5:51pm

Murphy Canyon Acquisition Corp. (NASDAQ:MURF) announced this afternoon that its stockholders voted in favor of the proposed business combination with Conduit Pharmaceuticals Limited (“Conduit”). Details on the vote, along with redemption numbers, have not been filed yet, but the Company expects the closing to occur as soon as practicable, subject to the satisfaction or waiver...

by Kristi Marvin on 2023-09-20 at 5:31pm

Latest SPAC Liquidations: Juniper II Corp. Juniper II Corp. (JUN) to Liquidate on October 10, 2023 Juniper II Corp. (NYSE: JUN), today announced that its board of directors has determined to redeem all of its outstanding shares of Class A common stock with such redemption anticipated to be effective as of October 10, 2023. The...


Copyright © 2023 SPACInsider, Inc. All Rights Reserved